Skip to content

NEWPHARMA

Active
Public limited companyfounded 201115 yrs activeRue Basse-Wez 315/317, 4020 Liège, BelgiumKBO/BCE: BE 0838.666.156

NEWPHARMA has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.52M and a net result of €273k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 20% of 4122 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).

Checked score

Score 2025
68 / 100
Healthy▲ +48 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability27▲+19
Solvency20▲+2
Growth64▼-4
Stability100
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €170k at 30 days acceptable
Liquidity tight (current ratio 1.14 against 1.1 in 2024), and 90.8% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Ten signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
9.2%
Return on assets
1%
Age of the figures
17 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 15 years 0 20 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 4122 sector peers (2025).
NBB · sector comparison
Position among 4122 sector peers
Solvency
better than 20%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 25-09-2025, 36 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
36 d early
2024
42 d early
2022
26 d early
2021
25 d early
2020
3 d early
2019
14 d late
2018
6 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today.
Companies Code · seven months
Position in the running window
31-03-2026 close14-09-2026 today31-10-2026 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover
€201.85M▼ 10.8%
2024 · €226.23M
2018: €81.77M 2019: €95.33M 2020: €145.12M 2021: €154.00M 2022: €162.84M 2024: €226.23M
2018 → 2025
EBIT margin
0.1%▲ 0.3pp
2024 · -0.2%
2018: 1.5% 2019: 0.4% 2020: -0.4% 2021: 0.5% 2022: -0.9% 2024: -0.2%
2018 → 2025
Net result
€273k
2024 · €-285k
2018: €290k 2019: €-498k 2020: €-1.80M 2021: €-273k 2022: €-1.39M 2024: €-285k
2018 → 2025
Working capital
€3.38M▲ 27.9%
2024 · €2.64M
2018: €1.21M 2019: €742k 2020: €1.46M 2021: €-33k 2022: €3.16M 2024: €2.64M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220242025Trend
Turnover€145.12M-€154.00M▲ 6.1%€162.84M▲ 5.7%€226.23M▲ 38.9%€201.85M▼ 10.8%
Equity€-810k-€-1.08M▼ 33.8%€2.53M€2.24M▼ 11.3%€2.52M▲ 12.2%
Operating result€-567k-€741k€-1.40M€-461k▲ 67.1%€124k
Net result€-1.80M-€-273k▲ 84.8%€-1.39M▼ 408%€-285k▲ 79.4%€273k
Result per fiscal year
Operating resultNet result
€-2.00M€-1.00M€0€1.00MOperating result 2020: €-567k€-567kNet result 2020: €-1.80M€-1.80MOperating result 2021: €741k€741kNet result 2021: €-273k€-273kOperating result 2022: €-1.40M€-1.40MNet result 2022: €-1.39M€-1.39MOperating result 2024: €-461k€-461kNet result 2024: €-285k€-285kOperating result 2025: €124k€124kNet result 2025: €273k€273k20202021202220242025
The operating result returns to profit in 2025: €124k after a loss of €461k in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €27.43M
Fixed assets €345k▼ 4.0%
Current assets €27.09M▼ 9.7%
Equity and liabilities €27.43M
Equity €2.52M▲ 12.2%
Provisions €340k▲ 1.5%
Debt €24.57M▼ 11.5%
The debt ratio falls from 91.5% to 89.6%: equity grows while debt is paid down.
Key figures and ratios
2025 value · change against 2024
EBITDA
€140k
2024 · €-441k
Cash flow
€289k
2024 · €-265k
Solvency
9.2%
2024 · 7.4%
Current ratio
1.14
2024 · 1.10
Quick ratio
0.55
2024 · 0.65
Debt / equity
9.76
2024 · 12.37
ROE
10.9%
2024 · -12.7%
ROA
1.0%
2024 · -0.9%
Interest coverage
10.99
2024 · -34.26
Debt
€24.57M
2024 · €27.76M
Debt ≤ 1 year
€23.70M
2024 · €27.33M
Income taxes
€2k
2024 · €6k
Staff costs
€1.25M
2024 · €1.53M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€30.34M€27.43M
Fixed assets21/28€359k€345k
Intangible fixed assets21€15k€9k
Tangible fixed assets22/27€138k€128k
Land and buildings22€136k€127k
Furniture and vehicles24€0€1k
Other tangible fixed assets26€3k€0
Financial fixed assets28€206k€208k
Affiliated companies280/1€57k€57k=
Participating interests280€57k€57k=
Other financial fixed assets284/8€149k€151k
Amounts receivable and cash guarantees285/8€149k€151k
Current assets29/58€29.98M€27.09M
Stocks and contracts in progress3€12.10M€14.09M
Stocks30/36€12.10M€14.09M
Raw materials and consumables30/31-€925
Goods purchased for resale34€12.10M€14.09M
Amounts receivable within one year40/41€9.80M€6.69M
Trade receivables40€3.37M€6.00M
Other amounts receivable41€6.43M€688k
Cash at bank and in hand54/58€7.07M€4.97M
Deferred charges and accrued income490/1€1.01M€1.34M
Equity and liabilities
Total equity and liabilities10/49€30.34M€27.43M
Equity10/15€2.24M€2.52M
Contributions10/11€5.05M€5.05M=
Capital10-€5.05M
Issued capital100-€5.05M
Reserves13€5k€5k=
Non-distributable reserves130/1€5k€5k=
Reserves not available under the articles1311€5k€5k=
Profit (loss) carried forward14€-2.81M€-2.54M
Provisions and deferred taxes16€335k€340k
Provisions for liabilities and charges160/5€335k€340k
Other liabilities and charges164/5€335k€340k
Amounts payable17/49€27.76M€24.57M
Amounts payable within one year42/48€27.33M€23.70M
Trade debts44€24.22M€20.40M
Suppliers440/4€24.22M€20.40M
Taxes, remuneration and social security45€3.11M€3.30M
Taxes450/3€2.88M€3.08M
Remuneration and social security454/9€232k€216k
Other amounts payable47/48€176€536
Accrued charges and deferred income492/3€425k€869k
Income statement Code20242025
Operating income70/76A€226.28M€201.88M
Turnover70€226.23M€201.85M
Other operating income74€43k€36k
Operating charges60/66A€226.74M€201.76M
Goods for resale, raw materials and consumables60€162.12M€144.87M
Purchases600/8€164.21M€146.84M
Change in stocks: decrease (increase)609€-2.08M€-1.97M
Services and other goods61€63.64M€55.55M
Remuneration, social security and pensions62€1.53M€1.25M
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€20k€16k
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€-421k€35k
Provisions for liabilities and charges: additions (uses and reversals)635/8€-257k€5k
Other operating charges640/8€107k€37k
Operating profit (loss)9901€-461k€124k
Financial income75/76B€247k€184k
Recurring financial income75€247k€184k
Income from current assets751€188k€136k
Other financial income752/9€60k€48k
Financial charges65/66B€66k€32k
Recurring financial charges65€66k€32k
Debt charges650€13k€13k
Other financial charges652/9€53k€20k
Profit (loss) for the period before taxes9903€-280k€276k
Income taxes67/77€6k€2k
Taxes670/3€6k€2k
Tax adjustments and reversals of tax provisions77-€33
Profit (loss) for the period9904€-285k€273k
Profit (loss) for the period to be appropriated9905€-285k€273k
Appropriation of the result
Profit (loss) to be appropriated9906€-2.81M€-2.54M
Profit (loss) brought forward from the previous period14P€-2.53M€-2.81M
Social balance
Average headcount (FTE)908714.714.6

The notes to these accounts (54 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-10-2026
2025
25-09
NBB filing Annual accounts filed
fiscal year 2025 · full schema
31-03
Financial Back to profitnet €273k
Net result €273k after 5 loss-making years.
2024
19-09
NBB filing Annual accounts filed
fiscal year 2024 · unclassified schema
2023
05-07
NBB filing Annual accounts filed
fiscal year 2022 · unclassified schema
2022
31-12
Financial Equity above €2MEq €2.53M
Equity rises from €-1.08M to €2.53M.
06-07
NBB filing Annual accounts filed
fiscal year 2021 · unclassified schema
2021
28-07
NBB filing Annual accounts filed
fiscal year 2020 · unclassified schema
2020
31-12
Financial Weakest financial yearnet €-1.80M
Net result drops to €-1.80M, the lowest in the series; recovery starts the following year.
14-08
NBB filing Annual accounts filed
fiscal year 2019 · full schema · 14 days late
2019
25-07
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
10-07
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
25-07
NBB filing Annual accounts filed
fiscal year 2016 · full schema
2016
28-09
NBB filing Annual accounts filed
fiscal year 2015 · full schema · 59 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
12 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Liège · 2 establishment units since 2011
establishment All 2 establishment units on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rue Basse-Wez 315/3174020 Liège
Ground area
2.8 ha
Building footprint
113 m²
Volume, LiDAR
891 m³
2 parcels, Wallonia · tallest building 10.8 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
NEWPHARMA
Rue Basse-Wez 315, 4020 LiègeRetail trade
since 20112.202.690.450
Newpharma
Rue du Charbonnage 9, 4020 LiègeOther postal and courier activities
since 20212.323.998.155
2 parcels
Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
62113B0166/00V000 Wallonia 2.8 ha - -
62817B0194/00D000 Wallonia 371 m² 1 · 113 m² 10.8 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

2 sites
Liège2.323.998.155
2 permissions
Apotheek (LM>3 maand) · since 31-03-2026
Detailhandel mengvoeders vee · since 31-03-2026
Liège2.202.690.450
1 permission
Apotheek (LM>3 maand) · since 01-12-2011

Similar companies · same sector, comparable size

Of 12,965 companies in sector 47120 we hold annual accounts for 2,177. 555 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded22-08-2011
Fiscal year end31-03
Activities, NACEBEL
47120Other non-specialised retail sale
47910Retail trade
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers

Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.